Misbah Tahir, Chief Financial Officer at IGM Biosciences, Inc. (IGMS), sold 1,337 shares at $5.06 ($7K) on 2023-11-27, disclosed to the SEC on 2023-11-29.
Seasonal sale ($7k) by Chief Financial Officer — this insider has traded IGMS in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2025-03-18 | $9K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $13K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $17K | — | Filing → |